Transdermal testosterone therapy: a potential treatment for selective serotonin reuptake inhibitor (SSRI)-associated sexual dysfunction in women [ 2011 - 2012 ]

Research Grant

Researchers: Prof Susan Davis (Principal investigator) ,  Prof Jayashri Kulkarni ,  Prof Robin Bell

Brief description Female sexual dysfunction (FSD) is frequently reported with selective serotonin reuptake inhibitor (SSRI) therapy and venlafaxine, these being the most common antidepressants used by Australian women. We have shown that testosterone therapy significantly improves sexual function in women with FSD. However SSRI-users have been excluded from these past studies. The aim of this study is to assess the efficacy of transdermal testosterone therapy for treatment of sexual dysfunction associated with SSRI therapy.

Funding Amount $AUD 241,351.01

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant